212 related articles for article (PubMed ID: 9416807)
1. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis.
Davie CA; Barker GJ; Thompson AJ; Tofts PS; McDonald WI; Miller DH
J Neurol Neurosurg Psychiatry; 1997 Dec; 63(6):736-42. PubMed ID: 9416807
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
[TBL] [Abstract][Full Text] [Related]
3. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
[TBL] [Abstract][Full Text] [Related]
4. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Paling D; Solanky BS; Riemer F; Tozer DJ; Wheeler-Kingshott CA; Kapoor R; Golay X; Miller DH
Brain; 2013 Jul; 136(Pt 7):2305-17. PubMed ID: 23801742
[TBL] [Abstract][Full Text] [Related]
5. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
6. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.
Davie CA; Barker GJ; Webb S; Tofts PS; Thompson AJ; Harding AE; McDonald WI; Miller DH
Brain; 1995 Dec; 118 ( Pt 6)():1583-92. PubMed ID: 8595487
[TBL] [Abstract][Full Text] [Related]
7. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
[TBL] [Abstract][Full Text] [Related]
8. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis.
Leary SM; Davie CA; Parker GJ; Stevenson VL; Wang L; Barker GJ; Miller DH; Thompson AJ
J Neurol; 1999 Nov; 246(11):1023-6. PubMed ID: 10631633
[TBL] [Abstract][Full Text] [Related]
9. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
[TBL] [Abstract][Full Text] [Related]
10. 1H MRSI of normal appearing white matter in multiple sclerosis.
Rooney WD; Goodkin DE; Schuff N; Meyerhoff DJ; Norman D; Weiner MW
Mult Scler; 1997 Aug; 3(4):231-7. PubMed ID: 9372505
[TBL] [Abstract][Full Text] [Related]
11. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.
Inglese M; Madelin G; Oesingmann N; Babb JS; Wu W; Stoeckel B; Herbert J; Johnson G
Brain; 2010 Mar; 133(Pt 3):847-57. PubMed ID: 20110245
[TBL] [Abstract][Full Text] [Related]
12. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.
Sarchielli P; Presciutti O; Pelliccioli GP; Tarducci R; Gobbi G; Chiarini P; Alberti A; Vicinanza F; Gallai V
Brain; 1999 Mar; 122 ( Pt 3)():513-21. PubMed ID: 10094259
[TBL] [Abstract][Full Text] [Related]
13. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
Thompson AJ; Kermode AG; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; McDonald WI
BMJ; 1990 Mar; 300(6725):631-4. PubMed ID: 2138923
[TBL] [Abstract][Full Text] [Related]
14. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
15. Cortical lesion load associates with progression of disability in multiple sclerosis.
Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
[TBL] [Abstract][Full Text] [Related]
16. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
[TBL] [Abstract][Full Text] [Related]
17. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
18. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
Caramanos Z; DiMaio S; Narayanan S; Lapierre Y; Arnold DL
J Neurol Sci; 2009 Jul; 282(1-2):72-9. PubMed ID: 19232641
[TBL] [Abstract][Full Text] [Related]
19. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study.
Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Orlacchio A; Gallai V
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):204-12. PubMed ID: 9489531
[TBL] [Abstract][Full Text] [Related]
20. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
